Eventful but stable 2010 for US health care sector, says Fitch report

8 April 2011

According to a new report issued yesterday by Fitch Ratings, the US health care sector experienced an eventful but stable 2010 as the Patient Protection and Affordable Care Act (ACA) was enacted and implementation of certain provisions of the bill began.

Macroeconomic conditions remain weak and top-line pressures persist; however, financial flexibility stemming from strong liquidity profiles and aided by management cost-cutting efforts and low cost inflation supported ratings in 2010. Overall, Fitch expects similar trends in credit profiles in 2011, with credit metrics trending near 2010 levels.

Volume and pricing pressures persist

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >